The Pennant Group, Inc. (PNTG) reported $289.32 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 53.2%. EPS of $0.34 for the same period compares to $0.24 a year ago.
The reported revenue represents a surprise of +5.97% over the Zacks Consensus Estimate of $273.04 million. With the consensus EPS estimate being $0.31, the EPS surprise was +8.52%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how The Pennant Group performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Home health and hospice services- Home health: $116.43 million versus $112.9 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +74.4% change.
- Revenue- Home health and hospice services- Hospice: $97.06 million versus $92.42 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +53.1% change.
- Revenue- Senior living services: $56.05 million versus the two-analyst average estimate of $57.06 million. The reported number represents a year-over-year change of +19.6%.
- Revenue- Total home health and hospice services: $233.27 million compared to the $220.6 million average estimate based on two analysts. The reported number represents a change of +64.3% year over year.
- Revenue- Home health and hospice services- Home care and other: $19.78 million versus the two-analyst average estimate of $15.28 million. The reported number represents a year-over-year change of +66.7%.
View all Key Company Metrics for The Pennant Group here>>>
Shares of The Pennant Group have returned +20.4% over the past month versus the Zacks S&P 500 composite's +0.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Pennant Group, Inc. (PNTG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
